Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1800 of 1863 entries
View as:

A Phase I Study of WT1 or NY-ESO-1 Vaccine and Nivolumab For Recurrent Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02737787 Org: User:
Start: 04/30/16 End: 04/06/23 Due: 04/06/24

A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide

Phase: N/A Priority: Normal
NCT ID: NCT03289741 Org: User:
Start: 09/19/17 End: 04/10/23 Due: 04/10/24

Anxiety in Black Men With Prostate Cancer: Validation of the Memorial Anxiety Scale for Prostate Cancer in an Sample of Black Men

Phase: N/A Priority: Normal
NCT ID: NCT00581672 Org: User:
Start: 07/25/10 End: 05/03/22 Due: 05/03/23

19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers

Phase: N/A Priority: Normal
NCT ID: NCT04464200 Org: User:
Start: 07/06/20 End: 07/31/26 Due: 07/31/27

Edotecarin in Treating Women With Locally Advanced or Metastatic Breast Cancer That Has Not Responded to Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00070031 Org: User:
Start: 06/30/03 End: 12/31/09 Due: 12/31/10

89Zr-DFO-REGN3767 in PET Scans in People With Diffuse Large B Cell Lymphoma (DLBCL)

Phase: N/A Priority: Normal
NCT ID: NCT04566978 Org: User:
Start: 09/11/20 End: 03/21/25 Due: 03/21/26

Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06066333 Org: User:
Start: 09/27/23 End: 09/27/26 Due: 09/27/27

CD8+ T Cell Imaging During Pre-surgery Immunotherapy in People With Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT05289193 Org: User:
Start: 03/11/22 End: 03/11/26 Due: 03/11/27

Acupuncture to Reduce Chemotherapy-induced Peripheral Neuropathy Severity During Neoadjuvant or Adjuvant Weekly Paclitaxel Chemotherapy in Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT02364726 Org: User:
Start: 02/09/15 End: 06/21/23 Due: 06/21/24

Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma

Phase: N/A Priority: Normal
NCT ID: NCT04577326 Org: User:
Start: 09/30/20 End: 09/30/25 Due: 09/30/26

Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19

Phase: N/A Priority: Normal
NCT ID: NCT00466531 Org: User:
Start: 03/21/07 End: 12/31/26 Due: 12/31/27

A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03693807 Org: User:
Start: 10/18/18 End: 06/27/24 Due: 06/27/25

Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery

Phase: N/A Priority: Normal
NCT ID: NCT04891289 Org: User:
Start: 05/07/21 End: 05/31/26 Due: 05/31/27

Easing Psychosocial Burden for Informal Caregivers

Phase: N/A Priority: Normal
NCT ID: NCT03454295 Org: User:
Start: 02/12/18 End: 03/26/24 Due: 03/26/25

The Sexual Health of Rectal Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00712751 Org: User:
Start: 06/24/08 End: 11/21/24 Due: 11/21/25

Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT03078010 Org: User:
Start: 02/10/17 End: 02/28/26 Due: 02/28/27

A Quality of Life Study in Patients Undergoing Percutaneous Biliary Drainage

Phase: N/A Priority: Normal
NCT ID: NCT03672019 Org: User:
Start: 09/11/18 End: 09/30/25 Due: 09/30/26

Study of MK-2206 in Patients With Metastatic Neuroendocrine Tumors (NET)

Phase: N/A Priority: Normal
NCT ID: NCT01169649 Org: User:
Start: 07/31/10 End: 02/28/14 Due: 02/28/15

A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)

Phase: N/A Priority: Normal
NCT ID: NCT05307939 Org: User:
Start: 03/24/22 End: 03/24/26 Due: 03/24/27

Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma

Phase: N/A Priority: Normal
NCT ID: NCT06037941 Org: User:
Start: 09/08/23 End: 09/30/25 Due: 09/30/26

Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes

Phase: N/A Priority: Normal
NCT ID: NCT02450708 Org: User:
Start: 05/31/15 End: 05/31/26 Due: 05/31/27

A Study of 68Ga-PSMA-11 PET Scans in People With Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06209567 Org: User:
Start: 01/05/24 End: 01/05/27 Due: 01/05/28

A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06807632 Org: User:
Start: 01/29/25 End: 01/31/27 Due: 01/31/28

Improving Surgeon Performance Measures for Robot-Assisted Surgery

Phase: N/A Priority: Normal
NCT ID: NCT06037837 Org: User:
Start: 08/24/23 End: 08/24/26 Due: 08/24/27

Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments

Phase: N/A Priority: Normal
NCT ID: NCT02296450 Org: User:
Start: 11/18/14 End: 11/30/25 Due: 11/30/26